Rapid Communication
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. May 21, 2006; 12(19): 3073-3076
Published online May 21, 2006. doi: 10.3748/wjg.v12.i19.3073
Table 2 Seminal and hormonal parameters in responders and non responders before, during and after treatment (mean ± SD)
Month 0
Month 6
Month 12
Month 0
Month 6
Month 12
Non respondersResponders
Sperm concentration (n/mL)84.2 ± 56.669.0 ± 35.566.6 ± 36.186.9 ± 76.635.2 ± 25.876.8 ± 75.3
Normal motility (%) 45.2 ± 7.051.4 ± 13.9 46.0 ± 7.446.2 ± 10.737.0 ± 17.843.8 ± 24.3
Normal morphology (%) 34.8 ± 7.624.6 ± 11.3 26.0 ± 6.8 21.4 ± 6.0 14.4 ± 9.221.6 ± 12.8
Inhibin B (pg/mL)98.0 ± 49.2 166.4 ± 30.3b95.4 ± 55.6 105.3 ± 50.1a 157.4 ± 72.7 143.4 ± 46.1
Free Testosterone (pg/mL) 16.2 ± 1.6 16.4 ± 2.0 16.9 ± 3.4 14.2 ± 2.5 14.6 ± 2.8 17.1 ± 2.6c
Total testosterone (µg/L)7.4 ± 2.07.9 ± 0.9d6.6 ± 1.06.0 ± 2.0 7.3 ± 2.16.9 ± 1.0
PRL (μg/L)7.0 ± 3.87.9 ± 1.88.9 ± 3.39.4 ± 6.37.4 ± 3.96.5 ± 2.8
LH (mU/mL)4.2 ± 2.13.6 ± 1.83.0 ± 1.23.8 ± 2.64.5 ± 2.53.6 ± 0.7
FSH (mU/mL)4.8 ± 1.74.9 ± 1.05.7 ± 1.64.8 ± 2.15.2 ± 0.85.1 ± 0.9
17-βE (pg/mL) 19.4 ± 5.3e 14.6 ± 5.1 20.2 ± 6.8 20.0 ± 7.9 12.7 ± 5.2 14.5 ± 2.8